[1] |
World Health Organization. Global tuberculosis report 2019[S]. Geneva:World Health Organization, 2019.
|
[2] |
郑扬, 夏辉, 赵雁林. TREK Sensititre MYCOTB检测结核分枝杆菌对一、二线抗结核药物的敏感性研究[J]. 中国防痨杂志, 2015,37(6):597-602.
|
[3] |
SSENGOOBA W, NAKAYITA G, NAMAGANDA C C, et al. Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing[J]. PLoS One, 2018,13(6):e0199638.
DOI
URL
|
[4] |
XIA H, ZHENG Y, ZHAO B, et al. Assessment of a 96-well plate assay of quantitative drug susceptibility testing for Mycobacterium tuberculosis complex in China[J]. PLoS One, 2017,12(1):e0169413.
DOI
URL
|
[5] |
LEE J, ARMSTRONG D T, SSENGOOBA W, et al. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs[J]. Antimicrob Agents Chemother, 2014,58(1):11-18.
DOI
URL
|
[6] |
冯通明, 肖美方, 王威, 等. 细菌超声分散计数仪在微生物实验前处理中的应用[J]. 结核病与肺部健康杂志, 2018,7(3):188-193.
|
[7] |
蔡杏珊, 刘燕文, 张院良, 等. 细菌超声分散计数仪在分枝杆菌药物敏感性试验中的应用价值[J]. 中国防痨杂志, 2016,38(11):963-967.
|
[8] |
江渊, 李静, 张阳奕, 等. 细菌超声分散计数仪在结核分枝杆菌药物敏感性试验中的应用价值[J]. 中华结核和呼吸杂志, 2017,40(4):289-293.
|
[9] |
National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria,nocardiae,and other aerobic actinomycets[S]. M24-A2,NCCLS, 2011.
|
[10] |
YU X, MA Y F, JIANG G L, et al. Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates[J]. Int J Tuberc Lung Dis, 2016,20(3):329-334.
DOI
URL
|
[11] |
GYGLI S M, KELLER P M, BALLIF M, et al. Whole-genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2019,63(4):e02175-18.
|
[12] |
JAGLAL P, PILLAY M, MLISANA K. Resazurin microtitre plate assay and Sensititre® MycoTB for detection of Mycobacterium tuberculosis resistance in a high tuberculosis resistance setting[J]. Afr J Lab Med, 2019,8(1):840.
|